NCT07039929View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

July 28, 2025

Primary Completion Date

January 3, 2026

Study Completion Date

January 3, 2026

Conditions

Healthy Participants

Interventions

DRUG

INCB000631

Oral; Tablet

DRUG

Placebo

Oral; Tablet

Trial Locations (1)

68502

RECRUITING

Celerion, Inc, Lincoln

Sponsors

Lead Sponsor

Incyte Corporation

All Listed Sponsors

lead

Incyte Corporation

INDUSTRY

NCT07039929 - Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants | Biotech Hunter | Biotech Hunter